TrialJournal of gastroenterology2019

A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study.

Fuyuhiko Motoi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.